Overview

Study Evaluating Etanercept in Patients With Ankylosing Spondylitis

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy of etanercept for the treatment of Ankylosing Spondylitis (AS).
Phase:
Phase 4
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Etanercept